167 related articles for article (PubMed ID: 10397553)
1. Complete regression of AIDS-related Kaposi's sarcoma in a child treated with highly active antiretroviral therapy.
Niehues T; Horneff G; Megahed M; Schroten H; Wahn V
AIDS; 1999 Jun; 13(9):1148-9. PubMed ID: 10397553
[No Abstract] [Full Text] [Related]
2. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma.
Lebbé C; Blum L; Pellet C; Blanchard G; Vérola O; Morel P; Danne O; Calvo F
AIDS; 1998 May; 12(7):F45-9. PubMed ID: 9619797
[TBL] [Abstract][Full Text] [Related]
3. Complete remission of AIDS/Kaposi's sarcoma after treatment with a combination of two nucleoside reverse transcriptase inhibitors and one non-nucleoside reverse transcriptase inhibitor.
Murdaca G; Campelli A; Setti M; Indiveri F; Puppo F
AIDS; 2002 Jan; 16(2):304-5. PubMed ID: 11807324
[No Abstract] [Full Text] [Related]
4. Potential interaction of antiretroviral therapy with paclitaxel in patients with AIDS-related Kaposi's sarcoma.
Schwartz JD; Howard W; Scadden DT
AIDS; 1999 Feb; 13(2):283-4. PubMed ID: 10202837
[No Abstract] [Full Text] [Related]
5. Patterns of lymphotropic herpesvirus viraemia in HIV-infected patients with Kaposi's sarcoma treated with highly active antiretroviral therapy and liposomal daunorubicin.
Torre-Cisneros J; Pozo F; Serrano R; Vidal E; Rivero A; Tenorio A
AIDS; 2000 Sep; 14(14):2215-7. PubMed ID: 11061671
[No Abstract] [Full Text] [Related]
6. Antiretroviral triple therapy decreases HIV viral load but does not alter hepatitis C virus (HCV) serum levels in HIV-HCV-co-infected haemophiliacs.
Rockstroh JK; Theisen A; Kaiser R; Sauerbruch T; Spengler U
AIDS; 1998 May; 12(7):829-30. PubMed ID: 9619824
[No Abstract] [Full Text] [Related]
7. A randomized clinical trial comparing nelfinavir or nevirapine associated to zidovudine/lamivudine in HIV-infected naive patients (the Combine Study).
Podzamczer D; Ferrer E; Consiglio E; Gatell JM; Perez P; Perez JL; Luna E; González A; Pedrol E; Lozano L; Ocaña I; Llibre JM; Casiró A; Aranda M; Barrufet P; Martínez-Lacasa J; Miró JM; Badía X; Casado A; Lupo S; Cahn P; Maños M; Estela J
Antivir Ther; 2002 Jun; 7(2):81-90. PubMed ID: 12212928
[TBL] [Abstract][Full Text] [Related]
8. HAART is effective as anti-Kaposi's sarcoma therapy only after remission has been induced by chemotherapy.
Vaccher E; di Gennaro G; Nasti G; Juzbasic S; Tirelli U
J Acquir Immune Defic Syndr; 1999 Dec; 22(4):407-8. PubMed ID: 10634205
[No Abstract] [Full Text] [Related]
9. Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma.
Bower M; Fox P; Fife K; Gill J; Nelson M; Gazzard B
AIDS; 1999 Oct; 13(15):2105-11. PubMed ID: 10546864
[TBL] [Abstract][Full Text] [Related]
10. Is switching protease inhibitor-based effective antiretroviral therapy safe in patients with AIDS-associated Kaposi's sarcoma?
Ridolfo AL; Corbellino M; Tosca N; Capelletti A; Scalamogna C; Galli M; Parravicini C
AIDS; 2004 May; 18(8):1224-6. PubMed ID: 15166546
[No Abstract] [Full Text] [Related]
11. Genotype and phenotype at baseline and at failure in human immunodeficiency virus-infected antiretroviral-naive patients in a randomized trial comparing zidovudine and lamivudine plus nelfinavir or nevirapine.
Ferrer E; Podzamczer D; Arnedo M; Fumero E; McKenna P; Rinehart A; Pérez JL; Barberá MJ; Pumarola T; Gatell JM; Gudiol F;
J Infect Dis; 2003 Feb; 187(4):687-90. PubMed ID: 12599088
[TBL] [Abstract][Full Text] [Related]
12. Antiretrovirals for HIV nephropathy?
Saag M; Hecht F
AIDS Clin Care; 1999 Jun; 11(6):50. PubMed ID: 11366883
[TBL] [Abstract][Full Text] [Related]
13. Reduction of Kaposi's sarcoma lesions following treatment of AIDS with ritonovir.
Conant MA; Opp KM; Poretz D; Mills RG
AIDS; 1997 Aug; 11(10):1300-1. PubMed ID: 9256954
[No Abstract] [Full Text] [Related]
14. Severe anoxic hepatic necrosis in an HIV-1-hepatitis C virus-co-infected patient starting antiretroviral triple combination therapy.
Karras A; Rabian C; Zylberberg H; Hermine O; Duchatelle V; Durand F; Valla D; Viard JP
AIDS; 1998 May; 12(7):827-9. PubMed ID: 9619823
[No Abstract] [Full Text] [Related]
15. Triple nucleoside combination zidovudine/lamivudine/abacavir versus zidovudine/lamivudine/nelfinavir as first-line therapy in HIV-1-infected adults: a randomized trial.
Matheron S; Descamps D; Boué F; Livrozet JM; Lafeuillade A; Aquilina C; Troisvallets D; Goetschel A; Brun-Vezinet F; Mamet JP; Thiaux C;
Antivir Ther; 2003 Apr; 8(2):163-71. PubMed ID: 12741629
[TBL] [Abstract][Full Text] [Related]
16. The extraordinary hope of antiretroviral therapy in South Africa (even for patients with tuberculosis or kaposi sarcoma!).
Flanigan TP; Campbell T; Harwell J; Kumarasamy N
J Infect Dis; 2005 Feb; 191(3):321-3. PubMed ID: 15633089
[No Abstract] [Full Text] [Related]
17. Chemotherapy in HIV-infected patients with Kaposi's sarcoma.
Pechère M; Krischer J; Rutschmann OT
Dermatology; 1997; 195(4):411-2. PubMed ID: 9529573
[No Abstract] [Full Text] [Related]
18. Regression of AIDS-related Kaposi's sarcoma associated with clearance of human herpesvirus-8 from peripheral blood mononuclear cells following initiation of antiretroviral therapy.
Wit FW; Sol CJ; Renwick N; Roos MT; Pals ST; van Leeuwen R; Goudsmit J; Reiss P
AIDS; 1998 Jan; 12(2):218-9. PubMed ID: 9468373
[No Abstract] [Full Text] [Related]
19. Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients. CISIH 92. Centre d'information et de soins de l'immunodéficience humaine.
Dupont C; Vasseur E; Beauchet A; Aegerter P; Berthé H; de Truchis P; Zucman D; Rouveix E; Saiag P
AIDS; 2000 May; 14(8):987-93. PubMed ID: 10853980
[TBL] [Abstract][Full Text] [Related]
20. Predictors of optimal virological response to potent antiretroviral therapy.
Powderly WG; Saag MS; Chapman S; Yu G; Quart B; Clendeninn NJ
AIDS; 1999 Oct; 13(14):1873-80. PubMed ID: 10513645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]